ABBOTT LABORATORIES — Director's Dealing 2007

Mar 13, 2007

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2007-03-09

Reporting Person: LIEPMANN HOLGER A (Executive Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2007-03-09	Common Shares without par value	M	11703	$42.4978	Acquired	149451	Direct
2007-03-09	Common shares without par value	M	18666	$41.69	Acquired	168117	Direct
2007-03-09	Common shares without par value	M	8761	$41.01	Acquired	176878	Direct
2007-03-09	Common shares without par value	M	12794	$41.0317	Acquired	189672	Direct
2007-03-09	Common Shares without par value	F	44784	$53.40	Disposed	144888	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2007-03-09	Option (right to by)	$42.4978	M	11703	Disposed	2009-02-11	Common Shares (11703)	Direct
2007-03-09	Option (right to by)	$41.69	M	18666	Disposed	2013-02-13	Common Shares (18666)	Direct
2007-03-09	Option (right to by)	$41.01	M	8761	Disposed	2010-02-10	Common Shares (8761)	Direct
2007-03-09	Option (right to by)	$41.0317	M	12794	Disposed	2014-02-19	Common Shares (12794)	Direct
2007-03-09	Option (right to buy)	$53.40	A	10067	Acquired	2009-02-11	common shares (10067)	Direct
2007-03-09	Option (right to buy)	$53.40	A	16187	Acquired	2013-02-13	common shares (16187)	Direct
2007-03-09	Option (right to buy)	$53.40	A	7530	Acquired	2010-02-10	common shares (7530)	Direct
2007-03-09	Option (right to buy)	$53.40	A	11000	Acquired	2014-02-19	common shares (11000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	13593	Indirect
Common shares without par value	295	Indirect
Common shares without par value	296	Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of March 12, 2007.

F2: Reporting person disclaims beneficial ownership of shares held by his daughters.

F3: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3.